Brian Nightengale, RPh, PhD

Inmar Intelligence

Brian Nightengale is the Executive Vice President and President, Healthcare Solutions at Inmar Intelligence. Prior to this role, he served as President, Community & Specialty Pharmacy &Long-Term Care, of Good Neighbor Pharmacy, which unites independent stores under one brand and leverages its scale, expertise and insights to help pharmacies drive better business decisions, increase growth and profitability and enhance patient care in local communities. Dr. Nightengale was President of Xcenda, part of AmerisourceBergen’s Consulting Services group. There he led more than 350 scientific, commercial, and market access professionals that help organizations across the life sciences industry demonstrate the value of pharmaceutical care and to maximize patient access to that care.

For over 25 years, Dr. Nightengale has worked with multiple biopharmaceutical research and manufacturing firms in developing product commercialization strategies and research programs across all phases of the product lifecycle. Dr. Nightengale has assisted in the design and implementation of innovative quality improvement programs and pharmaceutical care applications within health plans, provider organizations, and state agencies. He has published and presented numerous manuscripts, posters, and podium presentations. Dr. Nightengale has also managed and provided expert counsel on well over 200 outcomes research and strategy engagements.

Prior to joining Xcenda, Dr. Nightengale served as an Assistant Professor at the College of Pharmacy, University of Oklahoma Health Sciences Center where he is currently a member of their National Board of Advisors. Dr. Nightengale spent nearly 10 years working in independent retail and nuclear pharmacies.

Dr. Nightengale currently serves on the board of directors for the National Association of Chain Drug Stores, on the National Community Pharmacists Association Innovation Council Board, and American Pharmacists Association Corporate Supporters Council.

He received his Doctor of Philosophy in Pharmaceutical Sciences with an emphasis in health economics from the University of South Carolina. Prior to that, he received his Bachelor of Science degree in Pharmacy from the University of Oklahoma.